News
GoodRx shares are pulling back Tuesday morning. The stock had jumped over 30% Monday after the company announced a new ...
GoodRx will offer the GLP-1s for $499 a month, the lowest-ever out-of-pocket cost for the weight-loss medications.
GoodRx and Novo Nordisk launch a $499 monthly self-pay option for Ozempic and Wegovy, expanding access at 70,000 pharmacies ...
2d
StockStory.org on MSNWhy GoodRx (GDRX) Stock Is Trading Up Today
What Happened? Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 40.2% in the afternoon session after the company ...
GoodRx Holdings, Inc.'s partnership with Novo Nordisk highlights its vital role in direct-to-consumer drug pricing. Click ...
We recently published 12 Best Healthcare Stocks to Buy Under $30. GoodRx Holdings, Inc. (NASDAQ:GDRX) is one of the best ...
Interestingly, Wall Street firms largely believe the former will playout in the long run. According to The Wall Street ...
Healthcare tech company GoodRx (NASDAQ:GDRX) missed Wall Street’s revenue expectations in Q2 CY2025 as sales only rose 1.2% ...
2don MSN
Ozempic creator Novo Nordisk will sell weight loss drugs for cheaper through this new partnership
TheStreet. Telemedicine company GoodRx (GDRX) has been helping Americans find the cheapest way to buy drugs for years. Thanks ...
GoodRx (Nasdaq: GDRX) has teamed up with Novo Nordisk (NOV: N) to make all dose levels of Ozempic (semaglutide) and Wegovy ...
GDRX currently has a forward P/E ratio of 15.42, while LHCG has a forward P/E of 35.36. We also note that GDRX has a PEG ratio of 0.94. This figure is similar to the commonly-used P/E ratio, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results